RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GRTS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Gritstone Oncology Inc. stock price on Thursday moving between $2.52 and $2.94
(Updated on Mar 28, 2024)

Sell candidate since Mar 28, 2024 PDF

The Gritstone Oncology Inc. stock price fell by -8.21% on the last day (Thursday, 28th Mar 2024) from $2.80 to $2.57. During the last trading day the stock fluctuated 16.67% from a day low at $2.52 to a day high of $2.94. The price has risen in 6 of the last 10 days and is up by 14.73% over the past 2 weeks. Volume has increased on the last day by 268 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $5.79 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 4.70% during the next 3 months and, with a 90% probability hold a price between $2.16 and $3.15 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GRTS Signals & Forecast

The Gritstone Oncology Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $2.70. On a fall, the stock will find some support from the long-term average at approximately $2.41. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, March 21, 2024, and so far it has fallen -8.54%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Gritstone Oncology Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.25 and $2.18. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Gritstone Oncology Inc. finds support just below today's level at $2.25. If this is broken, then the next support from accumulated volume will be at $2.18 and $2.02.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.420 between high and low, or 16.67%. For the last week, the stock has had daily average volatility of 10.05%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GRTS) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Gritstone Oncology Inc. to open at $2.68, and during the day (based on 14 day Average True Range), to move between $2.31 and $2.83, which gives a possible trading interval of +/-$0.264 (+/-10.29%) up or down from last closing price. If Gritstone Oncology Inc. takes out the full calculated possible swing range there will be an estimated 20.57% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.63 (2.33%) than the support at $2.25 (12.45%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Gritstone Oncology Inc. stock A Buy?

Gritstone Oncology Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -1.729 Sell Candidate Downgraded

Predicted Opening Price for Gritstone Oncology Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$2.68 ( 4.15%) $2.57

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GRTS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.10 20.49 %
R2 2.94 14.25 %
R1 2.84 10.39 %
Current price: 2.57
Support S1 2.52 -2.09 %
S2 2.42 -5.95 %
S3 2.26 -12.19 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.90 12.84 %
R2 2.82 9.73 %
R1 2.63 2.33 %
Current price 2.57
Support S1 2.25 -12.45%
S2 2.18 -15.18%
S3 2.02 -21.40%

FAQ

What is the symbol for Gritstone Oncology Inc. Stock and on which exchange is it traded?
The symbol for Gritstone Oncology Inc. is GRTS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Gritstone Oncology Inc. Stock?
Gritstone Oncology Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

How to buy Gritstone Oncology Inc. Stock?
Gritstone Oncology Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Gritstone Oncology Inc. Stock.

What's the current price of Gritstone Oncology Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Gritstone Oncology Inc. (GRTS) share was $2.57.

What is the 52-week high and low for Gritstone Oncology Inc. Stock?
The 52-week high for Gritstone Oncology Inc. Stock is $3.33 and the 52-week low is $1.14.

What is the market capitalization of Gritstone Oncology Inc. Stock?
As of the 2024-03-28, the market capitalization of Gritstone Oncology Inc. is 252.029M.

When is the next earnings date for Gritstone Oncology Inc.?
The upcoming earnings date for Gritstone Oncology Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Gritstone Oncology Inc.

Gritstone Oncology. Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-she... GRTS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT